Xencor, Inc. (XNCR)
26.12
-2.76
(-9.54%)
USD |
NASDAQ |
Aug 28, 13:59
Xencor Debt to Equity Ratio : 0.338 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.338 |
| March 31, 2026 | 0.3397 |
| December 31, 2025 | 0.2954 |
| September 30, 2025 | 0.3237 |
| June 30, 2025 | 0.3433 |
| March 31, 2025 | 0.3473 |
| December 31, 2024 | 0.3423 |
| September 30, 2024 | 0.1196 |
| June 30, 2024 | 0.1554 |
| March 31, 2024 | 0.1458 |
| December 31, 2023 | 0.1248 |
| September 30, 2023 | 0.0908 |
| June 30, 2023 | 0.0867 |
| March 31, 2023 | 0.0867 |
| December 31, 2022 | 0.082 |
| September 30, 2022 | 0.0596 |
| June 30, 2022 | 0.056 |
| March 31, 2022 | 0.0457 |
| December 31, 2021 | 0.0463 |
| September 30, 2021 | 0.0553 |
| June 30, 2021 | 0.0078 |
| March 31, 2021 | 0.0191 |
| December 31, 2020 | 0.0203 |
| September 30, 2020 | 0.0168 |
| June 30, 2020 | 0.017 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0172 |
| December 31, 2019 | 0.0181 |
| September 30, 2019 | 0.0185 |
| June 30, 2019 | 0.0195 |
| March 31, 2019 | 0.02 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.0001 |
| March 31, 2014 | 0.0001 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Incyte Corp. | 0.006 |
| Regeneron Pharmaceuticals, Inc. | 0.0854 |
| MacroGenics, Inc. | 4.624 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 724.96M |
| Total Liabilities (Quarterly) | 221.73M |
| Shareholders Equity (Quarterly) | 503.23M |
| Current Ratio | 6.391 |
| Net Debt Paydown Yield | 0.87% |